In this section:

09 January 2018

Palmo-Plantar Pustulosis (PPP) Study Recruiting New Participants

The APRICOT trial is open at centres in locations across the UK.

PPP on the soles of the feet.

A study which is testing a potential new treatment for palmo-plantar pustulosis (PPP) is looking to recruit 40 new participants to start as soon as possible. PPP, pustular psoriasis of the palms of the hands and the soles of the feet, is an uncommon but painful and often debilitating form of psoriasis.

The study, Anakinra for Pustular Psoriasis: Response in a Controlled Trial (APRICOT), will test a medication called Anakinra to see if it improves PPP. The trial also hopes to collect information from participants that will help to explain how and why people get PPP.

This clinical trial is led by Professor Catherine Smith at St John’s Institute of Dermatology, and has been funded by the Efficacy and Mechanism Evaluation (EME) Programme, a Medical Research Council and National Institute for Health Research partnership. The Psoriasis Association is a collaborator on the project.

APRICOT is currently open at centres in London, Salford, Newcastle, Cardiff, Dundee, Bradford, Liverpool, Lancaster, Dudley, Bristol and Cambridge. The study is also due to open at a centre in Poole very soon.

For more information on the study, including how to take part in the clinical trial, please visit the APRICOT website.

The Psoriasis Association is the UK's leading national charity and membership organisation for people affected by psoriasis – patients, families, carers and health professionals Read More >

Get in touch

The Psoriasis Association Dick Coles House 2 Queensbridge Northampton NN4 7BF


Tel :
01604 251 620
Fax :
01604 251 621
Registered with Fundraising Regulator -

© The Psoriasis Association Registered Charity: 257414 Scotland: SC039886 Privacy PolicyCookies

Site by Spoken Image | glitterfish

We use cookies to help us provide you with a better service, but do not track anything that can be used to personally identify you.

If you prefer us not to set these cookies, please visit our Cookie Settings page or continue browsing our site to accept them.